Noblesville, Indiana (PRWEB) June 23, 2014
A recent study indicated that men who have known coronary artery heart disease and a low testosterone level have a higher chance of dying prematurely.
The study, published in the medical journal Heart, followed 930 men who had confirmed coronary artery disease, for a minimum of seven years. Twenty-four percent of the men had low testosterone. For those men with Low T, the mortality rate was more than doubled, compared with those who had normal serum testosterone levels.
The authors were unable to state whether low testosterone was the cause of the increased mortality in these men, or if low testosterone was only an indicator of increased mortality. They recommended further studies to assess whether the benefit of testosterone replacement therapy would increase survival rates in men with known coronary artery disease who have Low T.
Because of this correlation though, it is important to carefully monitor the potential cardiovascular risks for patients receiving testosterone replacement therapy. Dr. David McLaughlin, the Medical Directory at Men’s Specialty Health Centers in Noblesville, Indiana, evaluates and informs his Low T patients about their specific risk. They are then monitored for their response to subcutaneous pellets or injection therapy. Any necessary adjustments in care are made to ensure patient safety.
The main goal at Men’s Specialty Health Centers is to help patients suffering from low testosterone achieve a better quality of life through effective treatments. Dr. McLaughlin has over 30 years of experience in treating such hormone deficiencies. Low T patients looking to improve their quality of life are encouraged to contact Men’s Specialty Health Centers to learn more about how Dr. McLaughlin can safely and effectively manage their health.